{
  "drug_name": "sodium zirconium cyclosilicate",
  "nbk_id": "NBK568741",
  "url": "https://www.ncbi.nlm.nih.gov/books/NBK568741/",
  "scraped_at": "2026-01-11T15:39:10",
  "sections": {
    "monitoring": "The management of hyperkalemia is multidisciplinary because of its potential to induce cardiac arrest and severe weakness. Once hyperkalemia is diagnosed, the primary condition must be treated.Â Patients with hyperkalemia need cardiac monitoring, and nurses should be familiar with ECG features of hyperkalemia, which are often the first to appear. The pharmacist has to ensure that all nephrotoxic medications and agents that raise potassium are discontinued.\n\nIf the hyperkalemia is severe, the nephrologist should be consulted. If ECG changes are present, a cardiology consult should be made. Treatment to lower the high potassium should be ongoing. These patients need cardiac monitoring 24/7 until the hyperkalemia has resolved. The dietitian should educate the patient on a low potassium diet. For those with renal dysfunction, continued follow-up with a nephrologist is recommended. Only through open communication between members of the interprofessional team can the morbidity of hyperkalemia be avoided."
  }
}